Reaction Details Report a problem with these data
Target
Histone deacetylase 3
Ligand
BDBM50446480
Substrate
n/a
Meas. Tech.
ChEMBL_1287886 (CHEMBL3112170)
IC50
33000±n/a nM
Citation
 Bürli, RW; Luckhurst, CA; Aziz, O; Matthews, KL; Yates, D; Lyons, KA; Beconi, M; McAllister, G; Breccia, P; Stott, AJ; Penrose, SD; Wall, M; Lamers, M; Leonard, P; Müller, I; Richardson, CM; Jarvis, R; Stones, L; Hughes, S; Wishart, G; Haughan, AF; O'Connell, C; Mead, T; McNeil, H; Vann, J; Mangette, J; Maillard, M; Beaumont, V; Munoz-Sanjuan, I; Dominguez, C Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease. J Med Chem 56:9934-54 (2013) [PubMed]  Article 
Target
Name:
Histone deacetylase 3
Synonyms:
HD3 | HDAC3 | HDAC3_HUMAN | Histone deacetylase 3 (HDAC3) | Human HDAC3 | RPD3-2 | SMAP45
Type:
Enzyme
Mol. Mass.:
48829.55
Organism:
Homo sapiens (Human)
Description:
O15379
Residue:
428
Sequence:
MAKTVAYFYDPDVGNFHYGAGHPMKPHRLALTHSLVLHYGLYKKMIVFKPYQASQHDMCRFHSEDYIDFLQRVSPTNMQGFTKSLNAFNVGDDCPVFPGLFEFCSRYTGASLQGATQLNNKICDIAINWAGGLHHAKKFEASGFCYVNDIVIGILELLKYHPRVLYIDIDIHHGDGVQEAFYLTDRVMTVSFHKYGNYFFPGTGDMYEVGAESGRYYCLNVPLRDGIDDQSYKHLFQPVINQVVDFYQPTCIVLQCGADSLGCDRLGCFNLSIRGHGECVEYVKSFNIPLLVLGGGGYTVRNVARCWTYETSLLVEEAISEELPYSEYFEYFAPDFTLHPDVSTRIENQNSRQYLDQIRQTIFENLKMLNHAPSVQIHDVPADLLTYDRTDEADAEERGPEENYSRPEAPNEFYDGDHDNDKESDVEI
  
Inhibitor
Name:
BDBM50446480
Synonyms:
CHEMBL3110005
Type:
Small organic molecule
Emp. Form.:
C16H15NO2
Mol. Mass.:
253.2958
SMILES:
ONC(=O)C1[C@@H]([C@H]1c1ccccc1)c1ccccc1 |r|
Structure:
Search PDB for entries with ligand similarity: